##semicolon##
SARS-CoV-2, COVID-19, respiratory, gastrointestinal, neurological, ophthalmic, skin manifestations, procalcitonin.##submission.citations##
Arsenault C., Gage A., Kim M.K. et al. COVID-19 and resilience of healthcare systems in ten countries //Nat Med 28, –2022. –p. 1314–1324.
Assicot M., Gendrel D., Carsin H. et al. High serum procalcitonin concentrations in patients with sepsis and infection // Lancet, 341. –1993. –p. 515–518.
Ergashov M.M. (2023) The importance of C-reactive protein, Procalcitonin, and cytokines in determining the prospect of SARS-COV-2-associated pnumonia. // Horizon Journal of Humanity and Artificial Intelligence. Volume: 02 Issue: 06 | 2023, ISSN: 2835-3064 pages 167-171.
Ergashov M.M. The importance of C-reactive protein, Procalcitonin, and cytokines in determining the prospect of SARS-COV-2-associated pnumonia // Galaxy International Interdisciplinary Reasearch Journal (GIIRJ).11(4). –2023. –p. 480-483.
Ergashov M.M. The role of the procalcitonin test in the diagnosis and treatment of COVID – 19. III International Book Edition – The Best Young Scientist 2021. Volume: IX. P. 40-42.
Evans L., Rhodes A., Alhazzani W. et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 // Intensive Care Med 47(1). –2021. –p. 1181–1247.
Gilbert D.N. Procalcitonin as a biomarker in respiratory tract infection // Clinic Infectious Disease 52(4). –2021. –p. 346-350.
Hessels L., Speksnijder E., Paternotte N. et al. Procalcitonin-guided antibiotic prescription in patients with COVID-19: Multicenter Observational Cohort Study // Chest. –2023. –p. 125–127.
Huttner B.D., Catho G., Pano-Pardo J.R. et al. COVID-19: don't neglect antimicrobial stewardship principles! // Clin Microbiol Infect. –2020. –p. 808–810.
Jayani C., Jayarajah U., Riza R. Gastrointestinal manifestations in COVID-19 // Trans R Soc Trop Med Hyg. –2021. –p. 1362–1388.
Langford B.J., So M, Raybardhan S. et al. Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis // Clin Microbiol Infect 26: –2020 –p. 1622–1629.
Langford B.J., So M., Raybardhan S. et al. Antibiotic prescribing in patients with COVID-19: rapid review and meta-analysis // Clinical Microbiological Infect, 27. –2021. –p. 520–531.
Langford B.J., So M., Simeonova M. et al. Antimicrobial resistance in patients with COVID-19: a systematic review and meta-analysis // Lancet Microbe 4. –2023. –p. e179–e191.
Mahendra M., Nuchin A., Kumar R. et al. Predictors of mortality in patients with severe COVID-19 pneumonia–a retrospective study // Adv Respir Med 89: –2021. –p.135–144.
Meisner M. Procalcitonin-biochemistry and Maisner M. Procalcitonin: A New Innovative Infection Parameter. Biochemical and Clinical Aspects // Revised and expanded ed. Stuttgart: Thieme Verlag. –2000. p. 136–137.
Oblokulov A.R., Husenova Z.Z., Ergashev M.M. Procalcitonin as an indicator of antibacterial therapy in COVID-19 // Annals of the Romanian Society for Cell Biology, –2021. –p. 5220–5224.
Oblokulov A.R., Kholov U.A., Niyozov G.E. et al. Extrapulmonal manifestations of COVID-19 // Infection, immunity and pharmacology –scientific and practical journal.–2021. –p. 62–66.
Pepper D.J. Sun J., Rhee C. et al. Procalcitonin-guided antibiotic discontinuation and mortality in critically Ill adults: a systematic review and meta-analysis // Chest 15(5). –2019. –p.1109–1118.
Rothe K., Feihl S., Schneider J. et al. Rates of bacterial co-infections and antimicrobial use in COVID-19 patients: a retrospective cohort study in light of antibiotic stewardship // Eur J Clinical Microbiological Infectious Disease, 40. –2021. –p. 859–869.
Roy A., Powers H.R., Craver E.C. et al. Antibiotic stewardship: early discontinuation of antibiotics based on procalcitonin level in COVID-19 Pneumonia // J Clin Pharm Ther. –2022. –p. 243–247.
Tian J., Yuan X., Xiao J. et al. Clinical characteristics and risk factors associated with COVID-19 disease severity in patients with cancer in Wuhan, China: a multicentre, retrospective, cohort study // Lancet Oncology. –2020. –p. 893–903.
Wang R., Zhang X., Irwin D.M. et al. Emergence of SARS-like coronavirus poses new challenge in China // J. Infect. –2020. –p. 350–371.
Westblade L.F., Simon M.S., Satlin M.J. Bacterial coinfections in coronavirus disease 2019 // Trends Microbiol 29. –2021. –p. 930–941.
Whittaker A., Anson M., Harky A. Neurological Manifestations of COVID-19: A systematic review and current update // Acta Neurol Scand. –2020 –p. 14–22.
Wölfel R., Corman V.M., Guggemos W. et al. Virological assessment of hospitalized patients with COVID-2019 // Nature. –2020. –p. 465–469.
Yoshimoto F.K. The Proteins of Severe Acute Respiratory Syndrome Coronavirus-2 (SARS CoV-2 or nCOV19) the Cause of COVID-19 // Protein J. –2020. –p. 198–216.
Zou L., Ruan F., Huang M. et al. SARS-CoV-2 Viral Load in Upper Respiratory Specimens of Infected Patients // N Engl J Med. –2020. –p. 1177–1179.
Zumla A., Hui D.S., Azhar E.I. et al. Reducing mortality from 2019-nCoV: Host-directed therapies should be an option // Lancet. –2020. –p. 35–36.